Skip to main content

Neutra’s National Sales Team Gets Encouraging Reception at Several Large Retail Chains

Written by Customer Service on . Posted in Public Companies.

Katy, TX, Jan. 14, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Neutra Corporation’s (OTC PINK:NTRR) new national sales team reports it has received solid interest in VIVIS’ transdermal CBD products from multiple well-known nationwide and regional retail chains.
“Large retailers are seeing the success smaller outfits are having with hemp-based CBD,” said Neutra CEO Sydney Jim. “Now they want a piece of that action. VIVIS can give them that opening. The chains had a positive impression of our brand and the transdermal samples we provided. The stores particularly appreciated VIVIS’ insistence on testing and quality, which, of course, is our primary market differentiator. We’re optimistic about future co-operation and sales opportunities.”Unlike CBD derived from cannabis, hemp-based CBD, such as that used by VIVIS, does not produce a high. This makes it legal for use in many states that outlaw cannabis. Large retail chains can stock and sell hemp-based CBD products, like transdermal creams and ointments, without worry about potential legal implications. And the fact that VIVIS lab tests each batch of product to assure potency, purity and quality should be appealing to major chains and their customers, especially those customers hesitant to enter a CBD store.Demand for hemp-based CBD products continues its upward trend. According to market research group Brightfield, 40 percent of existing CBD users said they have increased their consumption in recent months. Prices from premium products have fallen, making quality offerings, such as those sold by VIVIS, more affordable for a greater number of buyers. Having its products stocked at major retail chains could bring in new customers who have never tried a hemp-based CBD product and greatly expand VIVIS’ market share. To learn more about VIVIS hemp-based CBD products, visit the company’s website at https://viviscorp.com.  After the migration of our new website, our site will return to http://viviscbd.com. About Neutra Corp.Neutra Corp. (NTRR) is an early-stage research and development company with a focus on bringing modern healthy living solutions to a multibillion-dollar market. Cutting-edge technologies within the nutraceuticals, food and drug, and environmental purification sectors are creating a new kind of world culture-one where in which consumers are demanding access to products that promote health and stave off potential health dangers. One of the nutraceutical sub-markets is the new thriving hemp-based CBD market, in which the Company intends to participate. For more information, visit the Company’s website at http://www.NeutraInc.com.NOTICE REGARDING FORWARD LOOKING STATEMENTSafe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words “believes,” “expects,” “anticipate” or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the company to differ materially from those expressed or implied by such forward-looking statements.Neutra Contact:Sydney Jim
888-433-4033
info@neutrainc.comSOURCE: Neutra Corp

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.